Reagenics Research
An Intelligent Bioreactors Platform to Produce Essential Plant Molecules
Startup Pre-Seed Agriculture & Food Technologies Est. 2019
Total Raised
$3M
Pre-Seed
Last Round
$3M
1 rounds
Team
5
1-10 employees
Confidence
100/100
News
9
articles
Patents
1
About
Reagenics Research is a dual-platform biotech company developing solutions for the production of essential molecules. It uses a variety of genetics to produce high-quality and valuable molecules from plant, algae, and mushroom cell tissue. Reagenics has the means to scale up production of plant cell biomass in proprietary bioreactors, which will ensure the security, supply, and quality of these essential molecules.
Classification
Sector
Agriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Core Technology
Materials & SubstancesRaw MaterialsBiologicalsCells
Target Customer
Energy, Utilities & Waste ManagementNew FuelsBiofuelsAgriculture & FoodProcessed FoodsBeveragesIngredientsCropsRow CropsBroadacreVineHealthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsBiotechnologyHealthcareLaboratories
Business Model
B2GB2B
Tags
stem-cellsplant-proteinfood-and-beveragecosmetic-companiesplant-protectionmedical-cannabisagtechbiotechnologymedical-technologiesagriculturebiomaterialsgastroenterologypharma-companies
Funding & Events
Oct 2021
Pre-Seed $3M
News (9)
Not applicable
Margot Stern - The Future of Protein Production
Not applicable
Jul 10, 2023 · agfundernews.com
growth-positive
ReaGenics cracks code to produce 'commercially viable' quantities of cannabinoids, other bioactives via plant cell culture
InvestmentPartners
May 30, 2023 · www.prnewswire.com
growth-positive
Up the Ladder: ReaGenics Promotes Jonny Cline to Chief Operations Officer
Management ChangesPartners
Apr 8, 2023 · www.jpost.com
growth-positive
Reagenics: Plant molecular harvesting in Israel Reagenics plant cells in bioreactors. The cells can be used for food products, dyes, vitamins and food additives.
Expand
Feb 21, 2023 · www.businesswire.com
growth-positive
KND Labs and ReaGenics Announce Partnership to Expand Business Lines
PartnersExpand
Feb 15, 2023 · www.newsrael.com
growth-positive
Israeli startup growing plant cells for pharma, in the lab
Expand
Feb 15, 2023 · www.mmjdaily.com
growth-positive
Growing plant cells for pharma in the lab: "Cannabis is challenging"
CustomersExpand
Feb 14, 2023 · www.israel21c.org
growth-positive
Growing plant cells for pharma, in the lab - ISRAEL21c
InvestmentExpand
Sep 20, 2019 · forward.com
growth-positive
Israel Wants To Be The Capital Of Medical Cannabis
InvestmentExpand
Details
Product Stage
R&D
Employees
1-10
Exact Count
5
District
Center District
Founded
2019
Registrar
515989192
Crunchbase
reagenics-research
Locations
Pinhas Sapir St 3, Ness Ziona, 7403626, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Sep 7, 2024
Verified by
Ortal Wein
Claimed
Yes
Missing
markets
Team (5)
Michael Kagan
Chairman
Founder
Eran Lagon
CEO
Jonny Cline
COO & EVP HR
Eliran Vaanunu
CTO
Margot Stern
Chief Strategy & Financial Officer
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2019-03-03T00:00:00.000Z
Last editor
Ortal Wein (ortalw@sncentral.org)